<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ichicsr SYSTEM "http://eudravigilance.ema.europa.eu/dtd/icsr21xml.dtd">
<ichicsr lang="en">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>265123_OBT</messagenumb>
		<messagesenderidentifier>SAAVTEST</messagesenderidentifier>
		<messagereceiveridentifier>ZWE_TEST</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20180430172702</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>1</safetyreportversion>
		<safetyreportid>ZW-SANOFI S.A.-2018SA000254</safetyreportid>
		<primarysourcecountry>ZW</primarysourcecountry>
		<occurcountry>ZW</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>20180430</transmissiondate>
		<reporttype>1</reporttype>
		<serious>1</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>20180424</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>20180424</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>ZW-SANOFI S.A.-2018SA000254</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<linkedreport>
			<linkreportnumb>US-SA-2017SA000001</linkreportnumb>
		</linkedreport>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>ZW</reportercountry>
			<qualification>1</qualification>
			<literaturereference>Nguyen TP, Takiar V, Garden AS et al.. Reirradiation of Head and Neck cancers with protons therapy : outcomes and Analyses. International. Journal of Radiation Oncology Biology Physics. 2016;96(1):30-35</literaturereference>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>SAAVTEST</senderorganization>
			<senderdepartment>Global Pharmacovigilance and Epidemiology</senderdepartment>
			<senderstreetaddress>1, avenue Pierre Brossolette</senderstreetaddress>
			<sendercity>Chilly-Mazarin</sendercity>
			<senderpostcode>91385</senderpostcode>
			<sendercountrycode>FR</sendercountrycode>
			<sendertel>999TEST</sendertel>
			<sendertelextension>9TEST</sendertelextension>
			<sendertelcountrycode>33</sendertelcountrycode>
			<senderfax>999TEST</senderfax>
			<senderfaxextension>9TEST</senderfaxextension>
			<senderfaxcountrycode>33</senderfaxcountrycode>
			<senderemailaddress>1050@foresightgroup.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZWE_TEST</receiverorganization>
			<receivercountrycode>ZW</receivercountrycode>
			<receivertel>999TEST</receivertel>
			<receivertelextension>9TEST</receivertelextension>
			<receiverfax>999TEST</receiverfax>
			<receiverfaxextension>9TEST</receiverfaxextension>
			<receiveremailaddress>1050@foresightgroup.com</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>PRIVACY</patientinitial>
			<patientinvestigationnumb>-</patientinvestigationnumb>
			<patientonsetage>30</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientagegroup>5</patientagegroup>
			<patientsex>1</patientsex>
			<resultstestsprocedures>Test Name: Full blood count,Date: , Result: 224 IU, Notes: ; 
</resultstestsprocedures>
			<parent>
				<parentidentification>PRIVACY</parentidentification>
			</parent>
			<reaction>
				<primarysourcereaction>insomnia</primarysourcereaction>
				<reactionmeddraversionllt>20.1</reactionmeddraversionllt>
				<reactionmeddrallt>10022437</reactionmeddrallt>
				<reactionmeddraversionpt>20.1</reactionmeddraversionpt>
				<reactionmeddrapt>10022437</reactionmeddrapt>
				<termhighlighted>4</termhighlighted>
				<reactionoutcome>2</reactionoutcome>
			</reaction>
			<test>
				<testname>10017411</testname>
				<testresult>224</testresult>
				<testunit>IU</testunit>
				<lowtestrange>20</lowtestrange>
				<hightestrange>30</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<drug>
				<drugcharacterization>1</drugcharacterization>
				<medicinalproduct>PLAVIX</medicinalproduct>
				<obtaindrugcountry>ZW</obtaindrugcountry>
				<drugbatchnumb>102</drugbatchnumb>
				<drugauthorizationcountry>ZW</drugauthorizationcountry>
				<drugstructuredosagenumb>10</drugstructuredosagenumb>
				<drugstructuredosageunit>012</drugstructuredosageunit>
				<drugcumulativedosagenumb>5</drugcumulativedosagenumb>
				<drugcumulativedosageunit>003</drugcumulativedosageunit>
				<drugdosagetext>10 ml, TOTAL</drugdosagetext>
				<drugdosageform>Film-coated tablet</drugdosageform>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>20180419</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>20180421</drugenddate>
				<drugtreatmentduration>3</drugtreatmentduration>
				<drugtreatmentdurationunit>804</drugtreatmentdurationunit>
				<actiondrug>5</actiondrug>
				<drugadditional>ExpDT=21-APR-2018</drugadditional>
				<activesubstance>
					<activesubstancename>CLOPIDOGREL BISULFATE</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>20.1</drugreactionassesmeddraversion>
					<drugreactionasses>10022437</drugreactionasses>
					<drugassessmentsource>Health Care professional</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>20.1</drugreactionassesmeddraversion>
					<drugreactionasses>10022437</drugreactionasses>
					<drugassessmentsource>Pharmaceutical Company</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
			</drug>
			<summary>
				<narrativeincludeclinical>This is a Narrative section.</narrativeincludeclinical>
			</summary>
		</patient>
	</safetyreport>
</ichicsr>
